Scilex Holding (SCLX) Inventory (2021 - 2026)
Scilex Holding (SCLX) posted quarterly Inventory of $4.5 million for Q1 2026, up 50.22% year-over-year from $3.0 million in Q1 2025, and down 5.37% on a QoQ basis from $4.8 million in Q4 2025.
Scilex Holding (SCLX) Inventory (2021 - 2026) Analysis & Trends
Scilex Holding (SCLX) has reported Inventory for 6 consecutive years, with $4.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory rose 50.22% year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $4.5 million (up 50.22% YoY), while the FY2025 annual figure was $4.8 million, up 96.59% from the prior year.
- Inventory came in at $4.5 million for Q1 2026 at Scilex Holding, down from $4.8 million in the prior quarter.
- The five-year high for Inventory was $4.8 million in Q4 2025, with the low at $1.1 million in Q3 2025.
- Average Inventory over 5 years is $3.0 million, with a median of $3.0 million recorded in 2024.
- Across the five-year window, Inventory soared 205.81% in 2023 and sank 54.99% in 2025, its largest moves.
- Year by year, Inventory stood at $1.4 million in 2022, then jumped by 205.81% to $4.2 million in 2023, then tumbled by 42.19% to $2.4 million in 2024, then jumped by 96.59% to $4.8 million in 2025, then fell by 5.37% to $4.5 million in 2026.
- According to Business Quant data, Inventory over the past three periods registered $4.5 million, $4.8 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 14.53 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 14.58 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 5.05 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 6.57 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 6.48 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 6.19 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 1.91 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 10.67 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Scilex Holding | 54.30 Mn | -95.62 Mn | 4.15 Mn | 4.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.53 Mn |
| Dec 31, 2025 | 4.79 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 2.52 Mn |
| Mar 31, 2025 | 3.02 Mn |
| Dec 31, 2024 | 2.44 Mn |
| Sep 30, 2024 | 2.40 Mn |
| Jun 30, 2024 | 3.07 Mn |
| Mar 31, 2024 | 3.49 Mn |
| Dec 31, 2023 | 4.21 Mn |
| Sep 30, 2023 | 3.94 Mn |
| Jun 30, 2023 | 3.11 Mn |
| Mar 31, 2023 | 2.28 Mn |
| Dec 31, 2022 | 1.38 Mn |
| Dec 31, 2021 | 2.56 Mn |